Scripscan:Zydus Wellness Ltd
cmp:170
Code:531335
Story:ZWL’s 3 branded products – Nutralite, Sugar Free and EevrYuth are solely owned by them. Nutralite is the only product manufactured in-house and the technology for the same is developed in-house itself. This results in no royalty outflow. ZWL
spends huge sums on building brand image of its products and this has resulted in it being one of the market leaders across all its products.Post the restructuring,Cadila’s CPD has been included under ZWL’s umbrella and this increases the scale ofoperations for the latter. This could lead to robust growth in revenues and thereby aid in attracting large number of investors. It would also facilitate alignment of assets so as to accelerate the consumer business. ZWL has cash surplus of Rs.15.3 cr prior to restructuring. Post restructuring with the assets and liabilities of CPD of Cadila being added this would generate free cash flow for ZWL, which could help in future expansions.ZWL is a large FMCG stock, which has performed well over the last few years. Its recent results showed a markedimprovement at the topline and bottomline. But this is due to the restructuring and inclusion of the business of Sugar Free and EverYuth in ZWL. Going forward, the revenues and profits are set to improve thereby making the stock available at decent valuations.I believe the ZWL’s brands could continue to be market leaders and outperform its competitors in various product categories.ZWL is a market leader across all its products and being a large FMCG stock is available at expensive valuations.I believe, the OPMs of ZWL could improve from 11.4% in FY08 to 17.1% in FY10 and ZWL could witness PAT growing at a CAGR of 136% over FY08-10 to Rs.26 cr (largely due to restructuring). At the CMP of Rs.170, the stock is trading at 23 x FY10(E) EPS.One can look at investing in ZWL in the 120-130 zone.
Thursday, August 20, 2009
Important Disclaimer&Privacy policy
This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: arunsharemarket@gmail.com
Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.
